HCA Healthcare stock trading at premium with strong fundamentals and growth potential

From Zacks Investment Research: 2024-12-24 16:06:22

U.S. hospital operator HCA Healthcare is trading at a premium compared to industry peers, with a forward P/E ratio of 12.28X. Despite this, the company’s strong cash flow and growth potential position it well for the future. HCA’s cash flow increased by 25.5% year-over-year, allowing for acquisitions and shareholder value. The company also reported growth in admissions and revenue per admission in the third quarter. Analysts predict a 15.2% increase in earnings for 2024 and a further 13.1% increase for 2025. While HCA’s stock has faced some decline, investors should consider the company’s strong fundamentals and growth prospects before making a decision.



Read more at Zacks Investment Research: HCA Healthcare Stock Trades at Premium: Time to Buy or Hold? – December 24, 2024